Skip to main content
SpringerLink
Log in

Irreversible Blockade von FGFR2-positiven intrahepatischen Cholangiokarzinomen – die FOENIX-CCA2-Studie kommentiert

Irreversible blockade of FGFR2-positive intrahepatic cholangiocarcinoma—a comment on the FOENIX-CCA2 study

  • Journal Club
  • Published:
Die Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Javle M, Lowery M, Shroff RT, Weiss KH, Springfeld C, Borad MJ et al (2018) Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma. J Clin Oncol 36:276–282. https://doi.org/10.1200/JCO.2017.75.5009

    Article  CAS  PubMed  Google Scholar 

  2. Saborowski A, Lehmann U, Vogel A (2020) FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next? Ther Adv Med Oncol 12:1758835920953293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Zhu AX, Macarulla T, Javle MM, Kelley RK, Lubner SJ, Adeva J et al (2021) Final overall survival efficacy results of Ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical ClarIDHy trial. JAMA Oncol 7:1669–1677

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Viszeral‑, Transplantations‑, Thorax- und Gefäßchirurgie, Universitätsklinikum Leipzig AöR, Liebigstr. 20, Haus 4, 04103, Leipzig, Deutschland

    Patrick Sven Plum &  Ines Gockel

  2. Institut für genomische Pathologie, Uniklinik Köln, Köln, Deutschland

    Axel Hillmer

  3. Klinik und Poliklinik für Allgemein‑, Viszeral‑, Tumor- und Transplantationschirurgie, Uniklinik Köln, Köln, Deutschland

    Hakan Alakus

Authors
  1. Patrick Sven Plum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ines Gockel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Axel Hillmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hakan Alakus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick Sven Plum.

Ethics declarations

Interessenkonflikt

P.S. Plum, I. Gockel, A. Hillmer und H. Alakus geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Plum, P.S., Gockel, I., Hillmer, A. et al. Irreversible Blockade von FGFR2-positiven intrahepatischen Cholangiokarzinomen – die FOENIX-CCA2-Studie kommentiert. Onkologie 29, 366–367 (2023). https://doi.org/10.1007/s00761-023-01335-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-023-01335-8

Search

Navigation